- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 34.5599 ↓ -1.14%
[as on 13 February, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth and its peers as on 13 February, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | -2.16% | -1.14% | 2.07% | -1.85% | -4% | 4.24% | 23.72% | 16.11% | 21.09% | 13.64% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -3.44% | -1.05% | 0.6% | -1.55% | -4.72% | 1.29% | 13.92% | 16.69% | 16.2% | 16.86% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.92% | -0.96% | -0.17% | -0.93% | -1.11% | 10.24% | 14.69% | 12.18% | 14.56% | 14.93% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | -0.71% | -1.01% | 1.53% | -0.77% | -3.47% | 3.79% | 25.54% | 16.87% | 21.41% | 13.46% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -1.43% | -1.21% | -0.35% | 1.76% | -1.33% | 8.93% | 22.39% | 21.1% | 21.08% | 18.32% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 5.59% | -1.19% | 1.43% | 5.81% | 6.15% | 30.1% | 35.14% | 29.88% | 23.35% | 18.01% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | -12.74% | 5.85% | -0.68% | 7.04% | 67.87% | 19.94% | -6.85% | 39.53% | 42.49% | -3.93% |
Discrete returns (monthly)
| Month | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 |
|---|
| Returns | 3.73% | -0.37% | 3.4% | 3.88% | -0.49% | -1.25% | 1.74% | 0.22% | -1.64% | -5.6% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | 13.9% | -2.44% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 98.47% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.53% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.59% |
| APOLLO HOSPITALS ENTERPRISE LTD | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.13% |
| HEALTHCARE GLOBAL ENTERPRISES LTD | HCG (INE075I01017) | Healthcare Services | 4.96% |
| LUPIN LTD | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.90% |
| MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 4.71% |
| TORRENT PHARMACEUTICALS LTD | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.52% |
| ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 4.42% |
| ABBOTT INDIA LTD | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 4.02% |
| CIPLA LTD | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.92% |
| IPCA LABORATORIES LTD | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.56% |
| AJANTA PHARMA LTD | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.35% |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 3.30% |
| ASTER DM HEALTHCARE LTD | ASTERDM (INE914M01019) | Healthcare Services | 3.29% |
| DIVI LABORATORIES LTD | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 3.26% |
| J.B.CHEMICALS & PHARMACEUTICALS LTD | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 3.22% |
| METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 3.18% |
| FDC LTD | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 2.93% |
| DR. LAL PATH LABS LTD | LALPATHLAB (INE600L01024) | Healthcare Services | 2.89% |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.63% |
| DR. AGARWALS HEALTH CARE LTD | AGARWALEYE (INE943P01029) | Healthcare Services | 2.33% |
| GLENMARK PHARMACEUTICALS LTD | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.17% |
| PI INDUSTRIES LTD | PIIND (INE603J01030) | Fertilizers & Agrochemicals | 2.17% |
| SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.09% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | KIMS (INE967H01025) | Healthcare Services | 2.01% |
| SYNGENE INTERNATIONAL LTD | SYNGENE (INE398R01022) | Healthcare Services | 1.76% |
| DR REDDYS LABORATORIES LTD | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.63% |
| COHANCE LIFESCIENCES LTD | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 1.51% |
| VIJAYA DIAGNOSTIC CENTRE LTD | VIJAYA (INE043W01024) | Healthcare Services | 1.50% |
| WOCKHARDT LTD | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.41% |
| AKUMS DRUGS AND PHARMACEUTICALS LTD | AKUMS (INE09XN01023) | Pharmaceuticals & Biotechnology | 0.89% |
| HIKAL LTD | HIKAL (INE475B01022) | Pharmaceuticals & Biotechnology | 0.71% |
| PFIZER LTD | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 0.42% |
| JUBILANT PHARMOVA LTD | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.06% |
| LAXMI DENTAL LTD | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.03% |
Portfolio data is as on date 31 October, 2025
NAV history
Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 13 February, 2026 | 34.5599 |
| 12 February, 2026 | 34.9589 |
| 11 February, 2026 | 35.0983 |
| 10 February, 2026 | 34.6563 |
| 9 February, 2026 | 34.3391 |
| 6 February, 2026 | 33.8602 |
| 5 February, 2026 | 33.9848 |
| 4 February, 2026 | 33.9426 |
| 3 February, 2026 | 34.0130 |
| 2 February, 2026 | 33.3470 |
| 30 January, 2026 | 33.4597 |
| 29 January, 2026 | 33.1143 |
| 28 January, 2026 | 33.4807 |
| 27 January, 2026 | 33.5076 |
| 23 January, 2026 | 33.5550 |
| 22 January, 2026 | 33.9979 |
| 21 January, 2026 | 33.8561 |
| 20 January, 2026 | 33.9913 |
| 19 January, 2026 | 34.6074 |
| 16 January, 2026 | 34.8246 |
| 14 January, 2026 | 35.0919 |
| 13 January, 2026 | 35.2102 |
| 12 January, 2026 | 35.1281 |
| 9 January, 2026 | 35.3109 |
| 8 January, 2026 | 35.6470 |
| 7 January, 2026 | 36.0780 |
| 6 January, 2026 | 35.9577 |
| 5 January, 2026 | 35.6612 |
| 2 January, 2026 | 35.5663 |
| 1 January, 2026 | 35.3245 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 34.5599 as on 13 February, 2026.
What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are -2.16% as on 13 February, 2026.
What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 4.24% as on 13 February, 2026.
What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 23.72% as on 13 February, 2026.
What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 16.11% as on 13 February, 2026.
What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 16.11% as on 13 February, 2026.